United States · FDA National Drug Code directory

Lansoprazole

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
27241-019_1e0a31f6-b245-43a0-81f4-8654c4b381d2
Product NDC
27241-019
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
Lansoprazole
Labeler
Ajanta Pharma USA Inc.
Marketing category
ANDA
Marketing start / end (source format)
20161018
Source listing expiry
20261231

Source-listed ingredients

  • LANSOPRAZOLE — 15 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-019-03) · 27241-019-03
  • 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-019-10) · 27241-019-10

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →